Week 2 - Discussion: The Psychiatric Evaluation and Evidence-Based Rating Scales

Instruct

io

ns:

Respon

d

to

your

colleague

by comparing your assessment tool

(Hamilton

Anxiety Rating Scale

(HAM

-

A)

)

to theirs

.

**minimum of three

(3)

scholarly references are required for each

reply

cited

within the body of the reply & at the end

**

Reply

#

1

Sabine

Jules

Week

2

Discussion

Main

Pos

t

There

needs

to

be

a

tool

that

can

accurately

assess

depression.

Depression

is

a

mood

disorder

that

affects

many

people

worldwide.

Depression

is

very

common

but

can

be

resistive

to

treatment.

Depression

is

considered

a

complex

problem

with

potentially

serious

economic

consequences

for

affected

individuals

as

well

as

the

public

healthcare

systems.

There

is

much

debate

among

laypersons,

patients,

academics,

and

clinicians

about

the

causes

of

depression(

Singh

&

Mastana,

(2015).

Th

e

Patient

Health

Questionnaire

-

9

(PHQ

-

9)

is

a

nine

item

questionnaire

designed

to

screen

for

depression

in

primary

care

and

other

medical

settings

(

Levis,

Benedetti,

&Thombs,

2019

)

This

is

primarily

used

in

all

health

care

settings.

It

is

the

preferred

rati

ng

scale

for

depression.

It

can

be

self

-

administered

or

administered

by

clinicians

.

The

PHQ

-

9

data

can

help

the

provider

understand

suicidal

ideation

in

it’s

targeted

population

.

This

test

looks

at

the

patient’s

symptoms

in

the

past

2

week

s

.

Ratings

of

t

he

questions

include

0=

not

at

all,

1=several

days,

2=more

than

half

of

the

days,

3=nearly

every

day.

The

scores

are

added

based

on

the

chosen

response

to

the

questions

.

This

test

is

appropriate

for

use

initially

and

at

continued

intervals

throughout

eval

uation

and

treatment.

It

is

best

used

with

a

combination

of

psychotherapy

and

psychopharmacology

as

a

management

tool

(

Costantini

et

al.

2021).

It

can

be

used

as

a

starting

point

for

diagnosing

depressing,

however,

a

practitioner

should

know

when

to

use

this

tool

.

Reference

s

Singh,

P.,

&

Mastana,

S.

(2015).

Depression

 

:

a

silent

culprit

in

health

and

diseas

e

.

Bentham

Science

Publishers,

Limited

.

Levis,

B.,

Benedetti,

A.,

Thombs,

B.

D.,

&

DEPRESsion

Screening

Data

(DEPRESSD)

Collaboration

(2019).

Accuracy

of

Patient

Health

Questionnaire

-

9

(PHQ

-

9)

for

screening

to

detect

major

depression:

individual

participant

data

meta

-

analysis.

BMJ (Clinical research ed.

)

,

36

5

,

l1476.

https://doi.org/10.1136/bmj.l1476

Costantini,

L.,

Pasquarella,

C.,

Odone,

A.,

Colucci,

M.

E.,

Costanza,

A.,

Serafini,

G.,

Aguglia,

A.,

Belvederi

Murri,

M.,

Brakoulias,

V.,

Amore,

M.,

Ghaemi,

S.

N.,

&

Amerio,

A.

(2021).

Screening

for

depression

in

primary

care

with

Patient

Health

Questionna

ire

-

9

(PHQ

-

9):

A

systematic

review.

Journal

of

Affective

Disorder

s

,

27

9

,

473

–

483.

https://doi.org/10.1016/j.jad.2020.09.131

Instructions:

Respond to your colleague by comparing your assessment tool (Hamilton Anxiety Rating Scale

(HAM-A)) to theirs.

**minimum of three (3) scholarly references are required for each reply cited

within the body of the reply & at the end**

Reply # 1

Sabine Jules

Week 2 Discussion Main Post

There needs to be a tool that can accurately assess depression. Depression is a mood disorder that

affects many people worldwide. Depression is very common but can be resistive to treatment. Depression

is considered a complex problem with potentially serious economic consequences for affected individuals

as well as the public healthcare systems. There is much debate among laypersons, patients, academics,

and clinicians about the causes of depression( Singh & Mastana, (2015).

The Patient Health Questionnaire-9 (PHQ-9) is a nine item questionnaire designed to screen for

depression in primary care and other medical settings ( Levis, Benedetti, &Thombs, 2019) This is

primarily used in all health care settings. It is the preferred rating scale for depression. It can be self-

administered or administered by clinicians. The PHQ-9 data can help the provider understand suicidal

ideation in it’s targeted population.

This test looks at the patient’s symptoms in the past 2 weeks. Ratings of the questions include 0= not at

all, 1=several days, 2=more than half of the days, 3=nearly every day. The scores are added based on the

chosen response to the questions.

This test is appropriate for use initially and at continued intervals throughout evaluation and treatment.

It is best used with a combination of psychotherapy and psychopharmacology as a management tool

( Costantini et al. 2021). It can be used as a starting point for diagnosing depressing, however, a

practitioner should know when to use this tool.

References

Singh, P., & Mastana, S. (2015). Depression : a silent culprit in health and disease. Bentham Science

Publishers, Limited.

Levis, B., Benedetti, A., Thombs, B. D., & DEPRESsion Screening Data (DEPRESSD) Collaboration

(2019). Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major

depression: individual participant data meta-analysis. BMJ (Clinical research ed.), 365,

l1476. https://doi.org/10.1136/bmj.l1476

Costantini, L., Pasquarella, C., Odone, A., Colucci, M. E., Costanza, A., Serafini, G., Aguglia, A.,

Belvederi Murri, M., Brakoulias, V., Amore, M., Ghaemi, S. N., & Amerio, A. (2021). Screening for

depression in primary care with Patient Health Questionnaire-9 (PHQ-9): A systematic review. Journal

of Affective Disorders, 279, 473–483. https://doi.org/10.1016/j.jad.2020.09.131